ACG 2025 Annual Scientific Meeting

Join GI physicians from the U.S. and around the world for the ACG Annual Scientific Meeting. ACG 2025 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

Wednesday, October 29, 2025 | ALL TIMES ARE LISTED IN MOUNTAIN TIME (MT)
8:15 am –
11:30 am
Registration Open
8:30 am –
12:15 pm
Annual Scientific Meeting
8:30 am –
10:15 am
Simultaneous Plenary Sessions 4
  • LIVESTREAM
    Plenary Session 4A
    (Abstracts 55-64)
  • Plenary Session 4B
    (Abstracts 65-74)
10:15 am –
10:20 am
Break
10:20 am –
10:50 am
LIVESTREAM
David Y. Graham Lecture

Introduced By: Amy S. Oxentenko, MD, FACG, ACG President

Sedation for Endoscopy: Facing the Future With Eyes Wide Open
Dayna S. Early, MD, FACG
Compare currently utilized endoscopic sedation models.

10:50 am –
11:00 am
Break
11:00 am –
12:15 pm
Simultaneous Symposia: Session 5

LIVESTREAM
Symposium 5A: Hot Off the Press: The Latest Recommendations for IBD Clinical Care
Moderator: Corey A. Siegel, MD, MS

  • Ulcerative Colitis Management in 2025
    Edward L. Barnes, MD, MPH, FACG
    Discuss the latest recommendations for UC care from the new ACG guideline.
  • Crohn’s Disease Care in 2025
    Anita Afzali, MD, MPH, MHCM, FACG
    Summarize the latest evidence-based care for Crohn’s disease from the new ACG guideline.
  • Should You Do Blue? Dysplasia and IBD
    Fernando S. Velayos, MD, MPH
    Evaluate recommendations for optimizing surveillance and management of dysplasia in IBD.

Symposium 5B: Managing Portal Hypertension: Do We Have a Consensus?
Moderator: Guadalupe Garcia-Tsao, MD, FACG

  • Baveno VII: Is This the End of Endoscopic Variceal Screen?
    Guadalupe Garcia-Tsao, MD, FACG
    Discuss guidance and significant updates from Baveno VII, including the role of fibrosis assessment rather than endoscopic evaluation of varices, and which patients will still need variceal screening.
  • Non-Selective Beta-Blockers: Are They for Everyone?
    Paul Y. Kwo, MD, FACG
    Discuss the current indications for beta blockade, optimum beta-blocker choices (including specific recommendations for carvedilol), and use in special populations, and contraindications.
  • Management of Acute Variceal Bleeding: Endoscopy, Interventional Radiology, and Beyond
    David E. Kaplan, MD
    Discuss the role of endoscopic variceal banding, stenting, hemostatic spray, alternative endoscopic therapies, sclerotherapy, and IR-guided therapies.
12:15 pm Annual Scientific Meeting Adjourns